IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.117
EU - Europa 32.602
AS - Asia 18.834
SA - Sud America 3.658
Continente sconosciuto - Info sul continente non disponibili 1.691
AF - Africa 1.236
OC - Oceania 75
AN - Antartide 1
Totale 101.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.141
GB - Regno Unito 7.468
IT - Italia 7.360
RU - Federazione Russa 6.030
SG - Singapore 5.900
CN - Cina 5.556
IE - Irlanda 2.972
BR - Brasile 2.969
VN - Vietnam 2.017
UA - Ucraina 1.687
HK - Hong Kong 1.606
FR - Francia 1.587
DE - Germania 1.576
SE - Svezia 1.515
FI - Finlandia 1.064
KR - Corea 989
BD - Bangladesh 725
ZA - Sudafrica 679
IN - India 528
CA - Canada 470
NL - Olanda 329
AR - Argentina 219
TR - Turchia 217
PL - Polonia 199
JP - Giappone 194
IQ - Iraq 192
ES - Italia 161
MX - Messico 160
EC - Ecuador 111
PK - Pakistan 111
ID - Indonesia 110
CI - Costa d'Avorio 104
CO - Colombia 97
AT - Austria 90
IL - Israele 89
NG - Nigeria 83
VE - Venezuela 82
CZ - Repubblica Ceca 79
KE - Kenya 78
BE - Belgio 76
LT - Lituania 69
AU - Australia 66
SA - Arabia Saudita 66
UZ - Uzbekistan 66
CL - Cile 63
MA - Marocco 62
CH - Svizzera 58
JM - Giamaica 54
MY - Malesia 52
CR - Costa Rica 51
EG - Egitto 46
IR - Iran 46
SC - Seychelles 46
AE - Emirati Arabi Uniti 43
PH - Filippine 43
HN - Honduras 42
NP - Nepal 39
DZ - Algeria 37
PE - Perù 36
SV - El Salvador 35
JO - Giordania 34
TT - Trinidad e Tobago 33
DK - Danimarca 32
PY - Paraguay 29
RO - Romania 29
EE - Estonia 27
GR - Grecia 27
KZ - Kazakistan 27
TN - Tunisia 27
UY - Uruguay 26
GP - Guadalupe 23
BY - Bielorussia 21
LB - Libano 21
BG - Bulgaria 20
BO - Bolivia 20
AL - Albania 19
NI - Nicaragua 19
PT - Portogallo 17
AZ - Azerbaigian 16
CW - ???statistics.table.value.countryCode.CW??? 16
ET - Etiopia 16
EU - Europa 16
HU - Ungheria 16
PR - Porto Rico 16
GT - Guatemala 15
PA - Panama 15
TH - Thailandia 15
OM - Oman 14
SN - Senegal 14
BH - Bahrain 13
BB - Barbados 12
DO - Repubblica Dominicana 12
LV - Lettonia 12
TW - Taiwan 12
KG - Kirghizistan 11
AM - Armenia 10
PS - Palestinian Territory 10
CY - Cipro 9
LY - Libia 9
NO - Norvegia 9
Totale 99.379
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Dallas 6.003
Singapore 3.559
Fairfield 3.338
Ashburn 3.299
Dublin 2.923
San Jose 2.119
Santa Clara 2.047
Milan 1.880
Chandler 1.704
Moscow 1.632
Woodbridge 1.585
Hong Kong 1.512
Wilmington 1.364
Houston 1.357
Jacksonville 1.340
Council Bluffs 1.322
Seattle 1.305
Hefei 1.294
Beijing 1.175
Cambridge 1.124
Seoul 971
Siena 859
Ann Arbor 840
Los Angeles 731
Rome 722
New York 689
The Dalles 680
Menlo Park 655
Helsinki 628
Johannesburg 620
Ho Chi Minh City 599
Princeton 544
Lauterbourg 508
Hanoi 488
Munich 462
Nanjing 454
Columbus 299
Buffalo 293
São Paulo 272
Boardman 269
Florence 264
San Mateo 232
San Diego 212
Chicago 197
Bengaluru 178
Düsseldorf 172
Figino 165
Orem 163
Dong Ket 161
London 145
Frankfurt am Main 143
Nanchang 141
Redondo Beach 136
Turin 132
Warsaw 127
Shenyang 126
Shanghai 118
Washington 117
North Bergen 116
Tokyo 115
Toronto 106
Abidjan 104
Naples 104
Dearborn 101
Montreal 101
Brooklyn 100
Turku 100
Phoenix 98
Atlanta 96
Rio de Janeiro 96
Nuremberg 93
San Francisco 91
Lappeenranta 89
Bologna 85
Changsha 85
Da Nang 85
Tianjin 85
Chennai 83
Denver 82
Haiphong 82
Abuja 80
Guangzhou 78
Boston 77
Hebei 68
Baghdad 67
Jiaxing 67
Belo Horizonte 64
Stockholm 64
Miami 62
Brasília 61
Jinan 60
Amsterdam 58
Brussels 57
Newark 57
Izmir 56
Tashkent 56
Bari 55
Manchester 54
Mexico City 53
Totale 66.374
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 940
A first update on mapping the human genetic architecture of COVID-19 628
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 609
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 570
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 532
Genetic mechanisms of critical illness in COVID-19 476
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 466
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 421
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 417
An explainable model of host genetic interactions linked to COVID-19 severity 407
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 407
Pathogen-sugar interactions revealed by universal saturation transfer analysis 390
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 382
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 381
Antiangiogenic VEGF isoform in inflammatory myopathies 381
Antirheumatic agents in covid-19: is IL-6 the right target? 377
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 370
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 367
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 361
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 355
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 352
Mapping the human genetic architecture of COVID-19 349
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 348
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 348
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 340
A case of amyloid myopathy in a patient with familial Mediterranean fever 339
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 336
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 335
Peripheral biomarkers' panel for severe COVID-19 patients 335
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 333
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 332
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 332
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 328
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 328
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 326
Colchicine myopathy and neuromyopathy: two cases with different characteristics 322
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 319
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 317
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 315
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 313
Clodronate in the management of different musculoskeletal conditions 312
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 311
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 307
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 304
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 303
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 301
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 298
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 293
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 292
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 290
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 289
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 287
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 286
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 286
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 285
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 282
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 282
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 281
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 281
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 281
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 278
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 278
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 274
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 274
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 268
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 265
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 265
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 262
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 262
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 261
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 261
Weekly oral alendronate in mevalonate kinase deficiency 260
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 260
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 259
Autoinflammatory disorders and patients with isolated serosal involvement. 257
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 256
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 256
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 255
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 254
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 254
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 253
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 252
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 252
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 251
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 251
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 249
Recommendations for the management of autoinflammatory diseases 249
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 249
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 248
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 248
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 247
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 247
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 247
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 246
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 244
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 244
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 242
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile Spondyloarthritis 242
Whole-genome sequencing reveals host factors underlying critical COVID-19 242
Clinical and biochemical landmarks in systemic autoinflammatory diseases 242
Totale 31.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.352 0 0 0 0 286 183 227 204 365 627 508 952
2022/20236.237 407 417 733 884 616 1.259 238 501 650 135 244 153
2023/20245.263 236 162 480 278 229 1.332 1.531 206 43 161 163 442
2024/202514.742 600 710 1.543 802 1.633 826 654 832 1.018 708 1.488 3.928
2025/202636.703 2.531 5.405 4.522 4.072 5.882 1.536 3.751 1.365 1.309 1.781 1.275 3.274
2026/20278.253 1.901 1.224 2.373 2.272 483 0 0 0 0 0 0 0
Totale 101.214